Vancomycin-resistant enterococci: mechanisms and clinical observations.
about
Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolonesCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciSelectivity for D-lactate incorporation into the peptidoglycan precursors of Lactobacillus plantarum: role of Aad, a VanX-like D-alanyl-D-alanine dipeptidase.Peptidoglycan O-acetylation increases in response to vancomycin treatment in vancomycin-resistant Enterococcus faecalisEvaluation of a rapid direct assay for identification of bacteria and the mec A and van genes from positive-testing blood culturesVirulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and miceEnterococcus faecium low-affinity pbp5 is a transferable determinantVancomycin resistance: small molecule approaches targeting the bacterial cell wall biosynthesis.Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilitiesDaptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.Comparative genomics of Enterococcus spp. isolated from bovine feces.Intrinsic and acquired resistance mechanisms in enterococcus.Development of a panel of recombinase polymerase amplification assays for detection of common bacterial urinary tract infection pathogens.Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.Uropathogens and host characteristicsVancomycin-Resistant Enterococci and Bacterial Community Structure following a Sewage Spill into an Aquatic Environment.Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species.Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.Colonization Rate and Risk Factors of Vancomycin-Resistant Enterococci among Patients Received Hematopoietic Stem Cell Transplantation in Shiraz, Southern Iran.Treatment strategies for infective endocarditis.Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.Antibiotic resistance in Enterococcus faecium clinical isolates.Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.Chemical Composition and Antimicrobial Activities of the Essential Oil From Salvia mirzayanii Leaves.Model systems for the study of Enterococcal colonization and infection.Isolation and characterisation of an enterocin P-producing Enterococcus lactis strain from a fresh shrimp (Penaeus vannamei).Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.Evaluation of the BD GeneOhm MRSA and VanR Assays as a Rapid Screening Tool for Detection of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in a Tertiary Hospital in Saudi Arabia.Buwchitin: A Ruminal Peptide with Antimicrobial Potential against Enterococcus faecalis.In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methodsSynthesis and binding studies of two new macrocyclic receptors for the stereoselective recognition of dipeptides.The VanRS Homologous Two-Component System VnlRSAb of the Glycopeptide Producer Amycolatopsis balhimycina Activates Transcription of the vanHAXSc Genes in Streptomyces coelicolor, but not in A. balhimycina.Comparison of PCR and culture for screening of vancomycin-resistant Enterococci: highly disparate results for vanA and vanB.Evaluation of a new molecular system for simultaneous identification of four Enterococcus species and their glycopeptide resistance genotypes.Detection of vancomycin resistances in enterococci within 3 ½ hours.Enterococcus in surface waters from the Des Moines River (Iowa) watershed: location, persistence and vancomycin resistance.[Incidence of vancomycin-resistant Enterococcus at a university hospital in Brazil].Molecular characterization of enterococci harboring genotype and phenotype incongruence related to glycopeptide resistance isolated in Brazilian hospitals.
P2860
Q26828604-C70A9BC5-A441-4D7D-9418-0FF405A42382Q26853465-4112F388-E8CC-4174-AB5C-89B493A2F9A1Q33280745-C417FF70-7720-49C9-8710-E1E63FCCD16EQ33559903-B7A3440F-7E3C-43F9-BB1C-8CE7C658D75CQ34073438-97012E1B-89D1-4CD5-B6EB-0742BF42313BQ34132052-E20E83F0-A442-499C-A84C-738A1BB13297Q34228346-81F510B0-7D77-45D1-9975-A616F56F9D78Q34587629-428156B4-2921-41C1-874C-7F42C052F4FBQ34640030-28DF531E-B3B2-468D-821A-6F5CC4BA4CE8Q36217683-A43F72FB-B373-4538-812F-9CADAE6BDFD5Q36264490-3F961233-E808-4338-BF2D-51FC70BC594BQ36300004-1933BDB4-7B26-4E8D-8C27-488A693F3315Q36362547-BB1472FD-932A-4252-89CF-D92D9C122B42Q36373340-07E2BF94-AC01-419D-8561-3715B96C4E4CQ36482313-850F5CBA-F43C-4EDE-93BA-DDA215728291Q36994482-2C440DC0-DEB2-4EC6-BCDF-9C95147F411BQ37224121-54C33B12-D040-4F0C-81F7-3BFE1A11CB7AQ37336208-468B5541-A569-43A0-957F-53FB1054ECFEQ37346968-D9C6743A-6317-4255-8605-A8F4817D70BFQ37569162-3CEC9E70-E04F-40E1-B4CD-1533233962D6Q37681564-6285D79C-84EE-4773-9402-FE14E77B4C27Q37722952-A1CA6DBD-7CCF-4CB1-BE5C-7FF360B03FA7Q38176042-746945E0-3766-4DC9-ADC4-63E1904A3A60Q38286351-3B220D84-6149-4A87-A165-DF897B2342A2Q38545589-2785BAEB-7746-4444-A6C0-CEEA9545721EQ38660817-E95F1EAA-A336-4443-84B6-939549C2F115Q38768532-B9245D0E-794E-4246-9EDA-0C543AC152E5Q38925852-FCEBC3B6-DC3F-40A6-B18C-E812DEBF4146Q39168565-B529D8F3-AEB5-4BA2-AA00-38F1BFC99939Q39751230-3527760E-03A1-427F-AB23-C6BCB785A262Q40117845-08589B04-6644-43EC-9098-77A4F9988F35Q40345198-C8C7BF3C-187D-4DE5-BAD6-F278FEF79A08Q40572617-A8098F76-90A6-4C32-A622-588C302F54EFQ40612247-5964CFB6-BE9B-429E-983A-A457BC6B1718Q42689057-788EA4E3-FDA0-4193-AEFA-3A8234CB7938Q42863710-7364B4BC-7712-4A1C-B3AA-643835E00CDBQ43128155-1420C4A7-3DE2-44A9-B9A5-1C34E6442F0EQ44103174-4D5E0648-27F9-42A5-B73D-50DF9A3EBB37Q45227149-BD4DE748-57F4-448D-980D-26AADB364367Q46508902-B9F75B43-EC9B-44F7-B6C2-7E52522A6CD0
P2860
Vancomycin-resistant enterococci: mechanisms and clinical observations.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@ast
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@en
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@nl
type
label
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@ast
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@en
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@nl
prefLabel
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@ast
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@en
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@nl
P2860
P356
P1476
Vancomycin-resistant enterococci: mechanisms and clinical observations.
@en
P2093
P2860
P304
P356
10.1086/321815
P407
P577
2001-06-14T00:00:00Z